Literature DB >> 1387576

An intracellular study of the action of NAN-190 on neurons in the dorsal raphe nucleus of the rat.

J P Hodgkiss1, I M Dawson, J S Kelly.   

Abstract

Intracellular recordings have been made from neurons in the dorsal raphe (DR) nucleus of the rat to determine the mechanism of action of the arylpiperazine compound NAN-190. Application of NAN-190 (50 microM) alone most frequently caused a hyperpolarization accompanied by a fall in RM and reduced the response to 5-HT and 8-OH-DPAT. After pretreatment of the preparation with the 5-HT-uptake blocker citalopram (10 microM) NAN-190 exerted an excitatory effect. It is concluded that NAN-190 is a partial agonist in the DR nucleus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387576     DOI: 10.1016/0006-8993(92)90623-h

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  1 in total

1.  The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.

Authors:  T Sharp; R McQuade; J R Fozard; D Hoyer
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.